| Number | Document Title | ID | Updated | Views |
|---|---|---|---|---|
| 21 | IND/IDE: Expiration Date | 101807 | 2026-02-25 | 596 |
| 22 | FDA Approval Date | 101806 | 2026-02-25 | 608 |
| 23 | IND/IDE Submit Date | 101805 | 2026-02-25 | 479 |
| 24 | Step Type (PC Treatment Tab) | 101814 | 2026-02-25 | 621 |
| 25 | IND/IDE Details: Holder Type | 43182 | 2026-02-25 | 733 |
| 26 | Sponsor Protocol No. | 101796 | 2026-02-25 | 617 |
| 27 | NCI/NIH Institution | 101803 | 2026-02-25 | 511 |
| 28 | Sponsor Type | 101795 | 2026-02-25 | 637 |
| 29 | Fund Account No. | 101797 | 2026-02-25 | 892 |
| 30 | Investigational Drug/Device | 101800 | 2026-02-25 | 508 |
| 31 | Principal Sponsor | 24517 | 2026-02-25 | 852 |
| 32 | IND/IDE Details: ID | 43181 | 2026-02-25 | 567 |
| 33 | Toxicity Scheme | 24235 | 2026-02-18 | 1093 |
| 34 | Pharmacy No. | 122680 | 2026-01-15 | 598 |
| 35 | Subject Visits Update OnCore Tutorial [Campus login required] | 42260 | 2026-04-12 | 98 |
Not finding what you are looking for? Suggest a new document be created, or try searching again with multiple search terms.